๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China flag China ยท Delayed Price ยท Currency is CNY
25.94
-0.65 (-2.44%)
Nov 20, 2026, 3:04 PM CST

SHE:300957 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
5,5325,3595,7365,7275,0144,022
Revenue Growth
6.74%-6.58%0.15%14.23%24.65%52.57%
Gross Profit
4,0953,9554,1704,2663,7523,045
Operating Income
510.72475.48420.76883.61,052948.45
Net Income
543.66505.72503.05756.81,051862.92
Earnings Per Share
1.291.201.201.792.482.12
EPS Growth
51.83%0%-32.96%-27.82%16.98%40.40%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Skin Care Products
4,5754,8014,8704,5573,629
Makeup
471.51550.52168.6253.1553.07
Medical Devices
264.83354.95463.11387.45325.85
Unallocated Service and Others
47.0429.1120.5516.1214.63
Total
5,3595,7365,5225,0144,022

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
3,8974,3084,2393,6404,4284,346
Total Debt
736.91834.5817.77213.9113.36125.2
Net Cash (Debt)
3,1603,4743,4213,4264,3154,221
Net Cash Growth
1.11%1.54%-0.14%-20.60%2.23%461.28%
Net Cash Per Share
7.508.248.168.1010.1810.37

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
851.44976.6694.87610.44769.451,153
Capital Expenditures
-93.58-482.99-378.38-274.28-353.42-270.68
Free Cash Flow
757.86493.61316.48336.16416.02882.04
Free Cash Flow Growth
33.27%55.97%-5.85%-19.20%-52.83%158.23%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
74.03%73.80%72.71%74.48%74.83%75.71%
Operating Margin
9.23%8.87%7.34%15.43%20.99%23.58%
Pretax Margin
11.63%11.51%10.61%15.17%24.21%25.31%
Profit Margin
9.83%9.44%8.77%13.21%20.97%21.45%
FCF Margin
13.70%9.21%5.52%5.87%8.30%21.93%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.5000.6500.6000.6000.8000.600
Dividend Per Share Growth
0%8.33%-0.08%-24.94%33.33%33.33%
Dividend Yield
1.93%1.65%1.41%0.88%0.54%0.31%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
20.0932.8935.6538.1660.1394.39
Forward PE
17.0523.3818.7919.3944.8275.64
P/FCF Ratio
14.2833.7056.6685.90151.9692.34
PS Ratio
1.963.103.135.0412.6120.25